Back to Journals » International Journal of Nanomedicine » Volume 2 » Issue 2

Nanoparticles in modern medicine: State of the art and future challenges

Authors Shashi K Murthy

Published 15 July 2007 Volume 2007:2(2) Pages 129—141

Shashi K Murthy

Department of Chemical Engineering, Northeastern University

Abstract: Nanoparticles are materials with overall dimensions in the nanoscale, ie, under 100 nm. In recent years, these materials have emerged as important players in modern medicine, with clinical applications ranging from contrast agents in imaging to carriers for drug and gene delivery into tumors. Indeed, there are some instances where nanoparticles enable analyses and therapies that simply cannot be performed otherwise. However, nanoparticles also bring with them unique environmental and societal challenges, particularly in regard to toxicity. This review aims to highlight the major contributions of nanoparticles to modern medicine and also discuss environmental and societal aspects of their use.

Keywords: nanoparticles, contrast agents, drug delivery, tumors, quantum dots, toxicity

Download Article [PDF] 

Readers of this article also read:

Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries

Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:571-576

Published Date: 14 September 2012

Study of the intra-arterial distribution of Fe3O4 nanoparticles in a model of colorectal neoplasm induced in rat liver by MRI and spectrometry

Echevarria-Uraga JJ, García-Alonso I, Plazaola F, Insausti M, Etxebarria N, Saiz-López A, Fernández-Ruanova B

International Journal of Nanomedicine 2012, 7:2399-2410

Published Date: 9 May 2012

The causes, consequences, and treatment of left or right heart failure

Pazos-Lopez P, Peteiro-Vazquez J, Garcia-Campos A, Garcia-Bueno L, Abugattas-de-Torres JP, Castro-Beiras A

Vascular Health and Risk Management 2011, 7:237-254

Published Date: 4 April 2011

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India

Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al

Vascular Health and Risk Management 2009, 5:1007-1014

Published Date: 20 November 2009

30-days mortality in patients with perforated peptic ulcer: A national audit

Anne Nakano, Jørgen Bendix, Sven Adamsen, Daniel Buck, Jan Mainz, et al

Risk Management and Healthcare Policy 2008, 1:31-38

Published Date: 30 November 2008

Assessment of anxiety and depression after lower limb amputation in Jordanian patients

Ziad M Hawamdeh, Yasmin S Othman, Alaa I Ibrahim

Neuropsychiatric Disease and Treatment 2008, 4:627-633

Published Date: 6 June 2008

RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker ανβ3 integrin with MR T1 mapping

Tianyi Ke, Eun-Kee Jeong, Xuli Wang, Yi Feng, Dennis L Parker, Zheng-Rong Lu

International Journal of Nanomedicine 2007, 2:191-199

Published Date: 15 July 2007